RadNet, Inc. (RDNT)
NASDAQ: RDNT · Real-Time Price · USD
71.29
+0.72 (1.02%)
Aug 27, 2025, 4:00 PM - Market closed
RadNet Revenue
RadNet had revenue of $498.23M in the quarter ending June 30, 2025, with 8.38% growth. This brings the company's revenue in the last twelve months to $1.91B, up 11.33% year-over-year. In the year 2024, RadNet had annual revenue of $1.83B with 13.18% growth.
Revenue (ttm)
$1.91B
Revenue Growth
+11.33%
P/S Ratio
2.77
Revenue / Employee
$211,986
Employees
9,000
Market Cap
5.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.83B | 213.03M | 13.18% |
| Dec 31, 2023 | 1.62B | 186.57M | 13.05% |
| Dec 31, 2022 | 1.43B | 105.87M | 8.00% |
| Dec 31, 2021 | 1.32B | 226.08M | 20.59% |
| Dec 31, 2020 | 1.10B | -56.08M | -4.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
RDNT News
- 23 hours ago - Coulda, Woulda, Shoulda: Are These 5 Stocks Too Overvalued to Buy Now? - Kiplinger
- 16 days ago - RadNet, Inc. (RDNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges - GlobeNewsWire
- 20 days ago - Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts - Seeking Alpha
- 4 weeks ago - RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call - GlobeNewsWire
- 7 weeks ago - Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet's AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California - GlobeNewsWire
- 2 months ago - RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives - GlobeNewsWire
- 3 months ago - RadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound Diagnostics - GlobeNewsWire